VIVEK SUBBIAH to Retreatment
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Retreatment.
Connection Strength
0.274
-
Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors. Clin Cancer Res. 2018 01 01; 24(1):43-51.
Score: 0.141
-
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Sci Rep. 2016 10 17; 6:35448.
Score: 0.132